www.fgks.org   »   [go: up one dir, main page]

Dow 25,119.89 55.53 0.22%
S&P 500 2,809.55 11.12 0.40%
Nasdaq 7,855.12 49.40 0.63%
GlobalDow 3,029.18 -2.58 -0.09%
Gold 1,225.10 -2.20 -0.18%
Oil 67.70 -0.38 -0.56%
DJIAUSClosedBack To Top
Last Updated: Jul 17, 2018 4:48 p.m. EDT

25,119.89

55.53 0.22%
Previous Close
25,064.36
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
Open: 25,033.92
Close: 25,119.89
24,989.61 Day Low/High 25,155.39
Day Range
21,471.14 52 Week Low/High 26,616.71

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open 25,033.92
  • Day Range 24,989.61 - 25,155.39
  • 52 Week Range 21,471.14 - 26,616.71

Performance

5 Day
  • 0.80%
1 Month
  • 1.70%
3 Month
  • 1.34%
YTD
  • 1.62%
1 Year
  • 16.43%

Recent News

  • MarketWatch
  • Other Dow Jones
Stock investors should not fear the inverted yield curve, strategist says

Stock investors should not fear the inverted yield curve, strategist says

Dow gains for 4th day in a row, Nasdaq logs record after earnings and Powell testimony

Dow gains for 4th day in a row, Nasdaq logs record after earnings and Powell testimony

2-year Treasury rate retakes 10-year high after Powell’s Senate testimony

Short-dated Treasury yields rise on Tuesday after Federal Reserve Chairman Jerome Powell, as expected, highlighted the need for a gradual pace of rate increases in testimony on Capitol Hill.

For the first time, Powell says more rate hikes are right path ‘for now’

For the first time, Powell says more rate hikes are right path ‘for now’

Breaking

Dow marks 4th straight gain as stocks finish broadly higher after Powell testimony

U.S. stock on Tuesday closed firmly higher and the technology-heavy Nasdaq notched a fresh record after Federal Reserve Chairman Jerome Powell indicated that the U.S. central bank would continue raising benchmark rates due the the health of the economy but would execute its monetary-policy strategy at a prudent pace. The Dow Jones Industrial Average closed up 0.2% at 25,119 (on a preliminary basis), marking its fourth straight positive finish in succession. The blue-benchmark's gains were buoyed by a rally in component Johnson & Johnson , which reported second-quarter earnings and revenue that were better than expected. Shares of the consumer-goods company gained 3.5% and contributed the lion's share of the equity index's Tuesday advance. The S&P 500 index closed up 0.4% at 2,809, while the Nasdaq Composite Index booked an all-time closing high, with a gain of 0.6% at 7,855. Providing testimony in front of the Senate Banking Committee, Powell said the "best way forward is to keep gradually raising the federal-funds rate for now." He will appear before a House committee on Wednesday. Meanwhile, economic reports supported the upbeat mood amid second-quarter corporate results that have mostly come out better than expected. Industrial production rose 0.6% in June to more than offset a similarly sized decline in May, the Federal Reserve said Tuesday. That was a tick above the MarketWatch forecast.

Dow marks fourth straight finish in the green

Dow marks fourth straight finish in the green

Nasdaq closes up 0.6%

Nasdaq closes up 0.6%

Dow closes up 0.2%; S&P 500 finishes with a gain of 0.4%

Dow closes up 0.2%; S&P 500 finishes with a gain of 0.4%

U.S. stocks end solidly higher on the heels of Day 1 of Powell testimony

U.S. stocks end solidly higher on the heels of Day 1 of Powell testimony

Breaking

Nasdaq books fresh record close

Nasdaq books fresh record close

Caterpillar ‘death cross’ snaps 566-session bullish streak

Caterpillar ‘death cross’ snaps 566-session bullish streak

GE earnings—No more drama, please

GE earnings—No more drama, please

Bitcoin prices sees biggest daily surge in three months, up more than 10%

Bitcoin prices surged more than 10% Tuesday, taking the No. 1 digital currency back above $7,000 for the first time in five weeks and on track to record its biggest daily gain since April 12. In doing so, bitcoin traded above its 50-day moving average, a closely watched momentum indicator. The rally for bitcoin has been aided by four consecutive winning days, which if gains hold also would represent its longest stretch since April. A single bitcoin last changed hands at $7,371.87, up 10.7% since Monday 5 p.m. on the Kraken crypto exchange. By comparison the Dow Jones Industrial Average has gained 0.3%, the S&P 500 is up 0.5% and the Nasdaq Composite Index is higher by 0.6%.

Breaking

Trump says he accepts U.S. intelligence that Russia meddled in election

President Donald Trump on Tuesday told reporters he accepts the assessment of U.S. intelligence that Russia meddled in the U.S. election. He added his administration would move aggressively to fight any efforts to interfere in 2018. On Monday, Trump said at a joint press conference with Vladimir Putin that he found the Russian president's denial "powerful."

IBM earnings: Security is growing fast, but is it enough money to matter?

IBM earnings: Security is growing fast, but is it enough money to matter?

Cellectar Biosciences shares surge 15% on results of one cancer patient in mid-stage trial

Cellectar Biosciences Inc. shares rose 15% in Tuesday trade after the company announced that one patient in a phase 2 trial for its cancer therapy had a major improvement in the amount of tumor material in her body, or an about 94% reduction. The trial, which is studying the therapy in patients with certain B-cell malignancies, intends to enroll about 80 participants total, according to Clinicaltrials.gov, and has an expected completion date of March 2019. The patient, who has a rare type of cancer called Waldenstrom macroglobulinemia, was administered two doses of the therapy, CLR 131, after which she showed the large reduction in tumor burden and complete resolution of four of five targeted tumor masses, the company said. Other symptoms that affected the patient's quality of life also improved, the treating physician, Dr. Sikander Ailawadhi, said. Importantly, the results of one patient may have no bearing on whether the trial is ultimately successful. Cellectar shares have surged 613% over the last three months, compared with a 3.8% rise in the S&P 500 and a 1.1% rise in the Dow Jones Industrial Average .

Fed Chairman Powell testifies before Congress — live video and blog

Fed Chairman Powell testifies before Congress — live video and blog

U.S. stocks turn positive; S&P 500 up 0.1%

U.S. stocks turn positive; S&P 500 up 0.1%

We’re in a ‘buying stampede,’ so get ready for new highs, says veteran strategist

We’re in a ‘buying stampede,’ so get ready for new highs, says veteran strategist

Johnson & Johnson shares rose 3.7% on Q2 earnings, revenue beats

Johnson & Johnson shares rose 3.7% in Tuesday morning trade after the company reported second-quarter earnings and revenue beats. Earnings for the latest quarter rose to $3.95 billion, or $1.45 per share, from $3.83 billion, or $1.40 per share in the year-earlier period. Adjusted earnings-per-share were $2.10, above the FactSet consensus of $2.07. Revenue rose to $20.83 billion from $18.84 billion, above the FactSet consensus of $20.39 billion. Pharmaceutical sales beat the consensus, with above-consensus sales for Simponi, Stelara, Prezisa/TMC, Concerta, Invega, Darzalex, Imbruvica and Zytiga, and below-consensus sales of Remicade, Edurant and Xarelto. Sales of medical devices also came in above the consensus. Yet consumer sales came in below consensus, with oral care and women's health sales above consensus, while baby care, oral care, skin care and wound care sales were below consensus. Johnson & Johnson now expects 2018 sales of $80.5 billion to $81.3 billion, reflecting an increase in expected operational growth and offset by an estimated lower favorable impact of currency; the guidance is below the FactSet consensus of $81.4 billion. Johnson & Johnson shares have dropped 0.7% over the last three months, compared with a 3.3% rise in the S&P 500 and a 1.1% rise in the Dow Jones Industrial Average .

Rising Inflation is Eroding Wage Gains

Prices for things like gasoline, food and housing are rising faster than U.S. consumers' wages, a potential threat to the U.S. expansion and the stock market.

  • on The Wall Street Journal

Don’t Ignore the Dow’s Discards

General Electric Co.’s removal from the Dow Jones Industrial Average this past week was a new low for the struggling industrial giant. But it could also be a sign of brighter days ahead.

  • on The Wall Street Journal

Investors Return Home as Small Caps Lead the Way

Investors are gobbling up the shares of small U.S. companies, a sign of how they're retreating from some overseas markets.

  • on The Wall Street Journal

How Companies Use the Latest Profits Fad to Fool You

Eighty-six years ago this week, the stock market hit its worst low. Today’s high-flying market looks like a polar opposite. But information is still power.

  • on The Wall Street Journal

Will Small Caps Lead Large Caps Higher? Don’t Bank on It

Shares of small companies are once again climbing to new highs, but that doesn't mean larger companies will follow suit.

  • on The Wall Street Journal

Investors Exit U.S. Equity Funds for Third Straight Month

U.S. stock funds are on track for a third straight month of outflows as investors grow wary of the aging bull market.

  • on The Wall Street Journal
Stock Indexes Cross Above Key Technical Level

Stock Indexes Cross Above Key Technical Level

  • on The Wall Street Journal
See Markets Sell Off on Trade Fears in Five Charts

See Markets Sell Off on Trade Fears in Five Charts

  • on The Wall Street Journal
Can a Strong Earnings Season Halt the Stock Market Slide?

Can a Strong Earnings Season Halt the Stock Market Slide?

  • on The Wall Street Journal
Stocks Can’t Escape the News

Stocks Can’t Escape the News

  • on The Wall Street Journal
The Market Selloff in 7 Charts

The Market Selloff in 7 Charts

  • on The Wall Street Journal
U.S. Stocks Show Persistence of Goldilocks Economy

U.S. Stocks Show Persistence of Goldilocks Economy

  • on The Wall Street Journal
Powell’s Fed Could Be More Volatile For Markets

Powell’s Fed Could Be More Volatile For Markets

  • on The Wall Street Journal
Investors Didn’t Sour on the Stock Market for Long

Investors Didn’t Sour on the Stock Market for Long

  • on The Wall Street Journal
The Stock Market Didn’t Get Tested—You Did

The Stock Market Didn’t Get Tested—You Did

  • on The Wall Street Journal
The Stock Market Selloff By the Numbers

The Stock Market Selloff By the Numbers

  • on The Wall Street Journal
Dow’s 5% Pullback Attracts Bargain Hunters

Dow’s 5% Pullback Attracts Bargain Hunters

  • on The Wall Street Journal
S&P 500 Has First 1% Decline Since August

S&P 500 Has First 1% Decline Since August

  • on The Wall Street Journal
Trump’s Stock Market Hyperbole

Trump’s Stock Market Hyperbole

  • on The Wall Street Journal
Wall Street Strategists Can’t Keep Up With the Stock Market

Wall Street Strategists Can’t Keep Up With the Stock Market

  • on The Wall Street Journal

Recent News

  • Other News

Competing With the Quants

Competing With the Quants

  • on GuruFocus.com

What Happened in the Stock Market Today

  • on Motley Fool

What Happened in the Stock Market Today

  • on Motley Fool

Oakmark Fund's Commentary: The World Cup and Investing

Oakmark Fund's Commentary: The World Cup and Investing

  • on GuruFocus.com

Why Art and Investing Have Much in Common

Why Art and Investing Have Much in Common

  • on GuruFocus.com

How to Get the Extra Money to Fuel Your Investments

How to Get the Extra Money to Fuel Your Investments

  • on GuruFocus.com

With General Electric Gone, Which Dow Component Will Be Kicked Out Next?

  • on Motley Fool

3 Things to Watch in the Stock Market This Week

  • on Motley Fool

What Happened in the Stock Market Today

  • on Motley Fool

T. Rowe Reports Slight Rise in Assets under Management in June

At the end of the second quarter, T. Rowe Price had assets under management of $1.04 trillion, a marginal rise month-over-month.

  • on MarketRealist.com

Should Investors Worry About Inflation After Higher-Than-Expected CPI Growth?

U.S. consumer prices rose for the third-consecutive month in June. Last month's price increases brought the CPI's growth from a year earlier to 2.9%, the highest monthly uptick in the last 4 years.

  • on Zacks.com

What Happened in the Stock Market Today

  • on Motley Fool

Cobas Funds Commentary: Investing Against the Consensus

Cobas Funds Commentary: Investing Against the Consensus

  • on GuruFocus.com

Mohamed El-Erian: What the Market Hasn't Realized About Trade War

Mohamed El-Erian: What the Market Hasn't Realized About Trade War

  • on GuruFocus.com

What Happened in the Stock Market Today

  • on Motley Fool

What Happened in the Stock Market Today

  • on Motley Fool

Royce Funds Commentary: The Economy Looks Normal--Why Don't the Markets?

Royce Funds Commentary: The Economy Looks Normal—Why Don’t the Markets?

  • on GuruFocus.com

7 Fascinating Facts About the Broad-Based S&P 500

  • on Motley Fool

What Happened in the Stock Market Today

  • on Motley Fool

3 Things to Watch in the Stock Market This Week

  • on Motley Fool

Major Stock Indexes

Key U.S. Last Chg Chg %
Dow Jones Industrial Average 25,119.89 55.53 0.22%
NASDAQ Composite Index 7,855.12 49.40 0.63%
S&P 500 Index 2,809.55 11.12 0.40%
Russell 2000 Index 1,687.26 8.72 0.52%
Other U.S. Last Chg Chg %
Dow Jones Transportation Average 10,463.13 27.61 0.26%
Dow Jones Utility Average Index 720.82 -0.23 -0.03%
Dow Jones U.S. Total Stock Market Index 29,236.35 125.42 0.43%
NASDAQ 100 Index (NASDAQ Calculation) 7,403.89 45.99 0.63%
S&P 400 Mid Cap Index 1,994.74 9.37 0.47%
NYSE Composite Index 12,779.22 30.44 0.24%
Barron's 400 Index 756.00 4.40 0.59%
CBOE Volatility Index 12.06 -0.77 -6.00%
Global Last Chg Chg %
Global Dow Realtime USD 3,029.18 -2.58 -0.09%
Asia/Pacific Last Chg Chg %
The Asia Dow Index USD 3,409.60 7.51 0.22%
S&P/ASX 200 Benchmark Index 6,241.2 37.6 0.61%
Shanghai Composite Index 2,815.42 17.29 0.62%
Hang Seng Index 28,232.67 50.99 0.18%
S&P BSE Sensex Index 36,646.11 126.15 0.35%
NIKKEI 225 Index 22,843.35 145.99 0.64%
FTSE Straits Times Index 3,250.11 10.47 0.32%
Europe Last Chg Chg %
STOXX Europe 50 Index 3,077.17 3.53 0.11%
STOXX Europe 600 Index 384.98 0.93 0.24%
CAC 40 Index 5,422.54 13.11 0.24%
DAX 12,661.54 100.52 0.80%
IBEX 35 Index 9,719.40 2.50 0.03%
FTSE 100 Index 7,626.33 25.88 0.34%
Americas Last Chg Chg %
BOVESPA Index 78,130.30 1,477.71 1.93%
S&P/TSX Composite Index 16,519.24 24.51 0.15%
IPC Indice de Precios Y Cotizaciones 48,704.63 250.42 0.52%

Index Components

Company Last Chg Chg %
Johnson & Johnson 129.11 4.42 3.54%
DowDuPont Inc. 67.06 1.34 2.04%
United Technologies Corp. 130.71 1.73 1.34%
Coca-Cola Co. 45.25 0.52 1.16%
Home Depot Inc. 201.10 2.22 1.12%
Microsoft Corp. 105.95 1.04 0.99%
VISA Inc. Cl A 139.64 1.18 0.85%
Pfizer Inc. 37.65 0.27 0.72%
Walgreens Boots Alliance Inc. 65.63 0.47 0.72%
Caterpillar Inc. 138.95 0.87 0.63%
Procter & Gamble Co. 80.03 0.50 0.63%
Walmart Inc. 88.19 0.55 0.63%
McDonald's Corp. 159.75 0.97 0.61%
3M Co. 202.07 0.96 0.48%
Travelers Cos. Inc. 128.79 0.60 0.47%
American Express Co. 101.15 0.46 0.46%
Apple Inc. 191.45 0.54 0.28%
Boeing Co. 356.88 0.78 0.22%
Walt Disney Co. 110.30 0.10 0.09%
JPMorgan Chase & Co. 110.50 -0.08 -0.07%
Merck & Co. Inc. 62.53 -0.06 -0.10%
Goldman Sachs Group Inc. 231.02 -0.42 -0.18%
Exxon Mobil Corp. 82.31 -0.18 -0.22%
Verizon Communications Inc. 51.43 -0.16 -0.31%
Nike Inc. Cl B 77.47 -0.28 -0.36%
Cisco Systems Inc. 42.34 -0.16 -0.38%
Intel Corp. 51.75 -0.26 -0.50%
Chevron Corp. 121.91 -1.07 -0.87%
International Business Machines Corp. 143.49 -1.97 -1.35%
UnitedHealth Group Inc. 250.29 -6.69 -2.60%

Partner Content